MedPath

Investigation of Berberis aristata root effect versus metformin tablet on blood sugar in diabetic patients .

Phase 2
Conditions
Diabet mellitus.
non insulin dependent diabetes mellitus
Registration Number
IRCT201207191774N5
Lead Sponsor
Physiology research center, Vice chancellor for Research and Technology of kerman medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Newly diagnosed type 2 diabetes based on ADA 2011 [14], 18-75 years old, Both sexes, Capable to swallow, No other tablet except metformine, No insulin therapy, No chronic inflammatory disease [17]
Exclusion criteria: Fasting blood sugar more than 250 mg/dl, HbA1C more than 10%, Patients with chronic complications of diabetes, Pregnancy, Lactation, Known liver, renal or neurologic diseases (based on clinical examination, interview with patient or previously endorsed documents with the patients).

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Plasma glucose. Timepoint: during of study. Method of measurement: blood sample.;Hba1c. Timepoint: after 3 month. Method of measurement: blood sample.;Fructose amin. Timepoint: after 2 weeks. Method of measurement: blood sample.
Secondary Outcome Measures
NameTimeMethod
aboratory Tests. Timepoint: after 0-15-45-90 days. Method of measurement: blood and urine sample.;Weight and blood prussre and others. Timepoint: after 0-15-45-90 days. Method of measurement: Barometer system and standard weight.
© Copyright 2025. All Rights Reserved by MedPath